Skip to main content

Advertisement

Log in

Dihydrodiol dehydrogenases regulate the generation of reactive oxygen species and the development of cisplatin resistance in human ovarian carcinoma cells

  • Original Article
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Abstract

We have previously demonstrated that overexpression of dihydrodiol dehydrogenase isoform 1 (DDH1) or DDH2 leads to the induction of drug resistance to platinum based drugs in human ovarian, lung, cervical and germ cell tumor cell lines. DDH belongs to a family of aldoketo reductases that are involved in the detoxification of several endogenous and exogenous substrates. DDH1 and DDH2 in particular have been shown to be involved in the detoxification (activation?) of polycyclic aromatic hydrocarbons (PAH). Based on the involvement of DDH in the detoxification of electrophilic PAH intermediates, the effect of DDH on the production of reactive oxygen species (ROS) in a cisplatin-sensitive and -resistant human ovarian carcinoma cell line was investigated in the current study. In addition to the overexpression of DDH1 and DDH2, increased expression of DDH3 was demonstrated in the cisplatin-resistant 2008/C13* cells, compared to the parental 2008 cells. However, as assessed by RT-PCR, neither cell line expressed DDH4. The 2008/C13* cells were eightfold resistant to cisplatin, and transfection experiments utilizing cisplatin-sensitive 2008 cells suggest that this could be mediated by overexpression of either DDH1, DDH2, or DDH3. The 2008/C13* cells had lower basal intracellular ROS level as compared to the 2008 cells and ROS production was decreased in the recombinant 2008 cells with forced, constitutive overexpression of either, DDH1, DDH2, or DDH3. Transfection of siRNA against DDH1 or DDH2 in the cisplatin-resistant 2008/C13* cells not only significantly decreased their cisplatin-resistance index (as assayed by MTT and colony formation assay) but also led to an increase in the basal levels of ROS production (although transfection of siRNA against DDH3 resulted in cell death). The 2008/C13* cells were found to be cross-resistant to the cytotoxic effects of hydrogen peroxide and tert-butyl hydroperoxide and knockdown of either DDH1 or DDH2 expression (using siRNA) resulted in sensitization of the resistant cells to these agents. These results support the conclusion that the increased levels of DDH in the 2008/C13* cells are directly responsible for the reduced production of ROS and that this may play a role in the development of cisplatin resistance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Andrew PA, Velury S, Mann SC, Howell SB (1988) cis-diamminedichloroplatinum (II) accumulation in sensitive and resistant human ovarian carcinoma cells. Cancer Res 48:68–73

    Google Scholar 

  2. Andrews PA, Albright KD (1992) Mitochondrial defects in cis-diamminedichloroplatinum (II)—resistant human ovarian carcinoma cells. Cancer Res 52:1895–1901

    PubMed  CAS  Google Scholar 

  3. Ax W, Soldan M, Koch L, Maser E (2000) Development of duanorubicin resistance in tumor cells by induction of carbonyl reductase. Biochem Pharmacol 59:293–300

    Article  PubMed  CAS  Google Scholar 

  4. Biroccio A, Benassi B, Amodei S, Gabellini C, Del Bufalo D, Zupi G (2001) c-Myc down-regulation increases susceptibility to cisplatin through reactive oxygen species-mediated apoptosis in M14 human melanoma cells. Mol Pharmacol 60:174–182

    PubMed  CAS  Google Scholar 

  5. Burczynski ME, Lin HK, Penning TM (1999) Isoform-specific induction of a human aldo-keto reductase by polycyclic aromatic hydrocarbons (PAHs), electrophiles, and oxidative stress: implications for the alternative pathway of PAH activation catalyzed by human dihydrodiol dehydrogenase. Cancer Res 59:607–614

    PubMed  CAS  Google Scholar 

  6. Christen RJ, Jekunen AP, Jones JA, Thiebaut F, Shalinsky DR, Howell SB (1993) In vitro modulation of cisplatin accumulation in human ovarian carcinoma cells by pharmacological alteration of microtubules. J Clin Invest 92:431–440

    Article  PubMed  CAS  Google Scholar 

  7. Chung YM, Yoo YD, Park JK, Kim YT, Kim HJ (2001) Increased expression of peroxiredoxin II confers resistance to cisplatin. Anticancer Res 21:1129–1133

    PubMed  CAS  Google Scholar 

  8. Ciaccio PJ, Stuart JE, Tew KD (1993) Overproduction of a 37.5-kDa cytosolic protein structurally similar to prostaglandin F synthase in ethacrynic acid-resistant human colon cells. Mol Pharmacol 43:845–853

    PubMed  CAS  Google Scholar 

  9. Deng HB, Parekh HK, Chow KC, Simpkins H (2002) Increased expression of dihydrodiol dehydrogenase induces resistance to cisplatin in human ovarian carcinoma cells. J Biol Chem 277:15035–15043

    Article  PubMed  CAS  Google Scholar 

  10. Deng HB, Adikari M, Parekh HK, Simpkins H (2004) Ubiquitous induction of resistance to platinum drugs in human ovarian, cervical, germ-cell and lung carcinoma tumor cells overexpressing isoforms 1 and 2 of dihydrodiol dehydrogenase. Cancer Chemother Pharmacol 54:301–307

    Article  PubMed  CAS  Google Scholar 

  11. Gebauer G, Mirakhur B, Nguyen Q, Shore SK, Simpkins H, Dhanasekaran N (2000) Cisplatin-resistance involves the defective processing of MEKK1 in human ovarian adenocarcinoma 2008/C13 cells. Int J Oncol 16:321–325

    PubMed  CAS  Google Scholar 

  12. Gius D, Spitz DR (2006) Redox signaling in cancer biology. Antioxid Redox Signal 8:1249–1252

    Article  PubMed  CAS  Google Scholar 

  13. Hamers T, Molin KR, Koeman JH, Murk AJ (2000) A small-volume bioassay for quantification of the esterase inhibiting potency of mixtures of organophosphate and carbamate insecticides in rainwater:development and optimization. Toxicol Sci 58:60–67

    Article  PubMed  CAS  Google Scholar 

  14. Isonishi S, Jekunen AP, Hom DH, Eastman A, Edelstein PS, Thiebaut FB, Christen RD, Howell SB (1992) Modulation of cisplatin sensitivity and growth rate of an ovarian carcinoma cell line by bombesin and tumor necrosis factor α. J Clin Invest 90:1436–1442

    Article  PubMed  CAS  Google Scholar 

  15. Jeong WS, Jun M, Kong AN (2006) Nrf2: a potential molecular target for cancer chemoprevention by natural compounds. Antioxid Redox Signal 8:99–106

    Article  PubMed  CAS  Google Scholar 

  16. Loehrer PJ, Einhorn LH (1984) Drugs five years later. Cisplatin Ann Intern Med 100:704–713

    CAS  Google Scholar 

  17. Mamenta EL, Poma EE, Kaufmann WK, Delmastro DA, Grady HL, Chaney SG (1994) Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines. Cancer Res 54:3500–3505

    PubMed  CAS  Google Scholar 

  18. Mann SC, Andrews PA, Howell SB (1991) Modulation of cis-diamminedichloroplatinum (II) accumulation and sensitivity by forkolin and 3 isobutyl-1 methylxanthine in sensitive and resistant human ovarian carcinoma cells. Int J Cancer 48:866–872

    Article  PubMed  CAS  Google Scholar 

  19. Mirakhur B, Parekh HK, Simpkins H (1996) Expression of the cisplatin resistance phenotype in a human ovarian carcinoma cell line segregates with chromosome 11 and 16. Cancer Res 56:2256–2262

    PubMed  CAS  Google Scholar 

  20. Moorehead RA, Singh G (2000) Influence of the proto-oncogene c-fos on cisplatin sensitivity. Biochem Pharmacol 59:337–345

    Article  PubMed  CAS  Google Scholar 

  21. Mattiasson G (2004) Analysis of mitochondrial generation and release of reactive oxygen species. Cytometry A 62:89–96

    Article  PubMed  Google Scholar 

  22. Ogasawara H, Nishio K, Kanzawa F, Lee YS, Funayama Y, Ohira T, Kuraishi Y, Isogai Y, Saijo N (1995) Intracellular carboxyl esterase activity is a determinant of cellular sensitivity to the antineoplastic agent KW-2189 in cell lines resistant to cisplatin and CPT-11. Jpn J Cancer Res 86:124–129

    PubMed  CAS  Google Scholar 

  23. Ozols RF, Williams SD (1989) Testicular cancer. Curr Prob Cancer 13:287–335

    Article  Google Scholar 

  24. Parekh HK, Simpkins H (1995) The differential expression of cytokeratin 18 in cisplatin-sensitive and -resistant human ovarian adenocarcinoma cells and its association with drug sensitivity. Cancer Res 55:5203–5206

    PubMed  CAS  Google Scholar 

  25. Penning TM, Burczynski ME, Jez JM, Hung CF, Lin HK, Ma H, Moore M, Palackal N, Ratnam K (2000) Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. Biochem J 351:67–77

    Article  PubMed  CAS  Google Scholar 

  26. Smithgall TE, Harvey RG, Penning TM (1986) Regio- and stereospecificity of homogeneous 3 alpha-hydroxysteroid-dihydrodiol dehydrogenase for trans-dihydrodiol metabolites of polycyclic aromatic hydrocarbons. J Biol Chem 261:6184–6191

    PubMed  CAS  Google Scholar 

  27. Smithgall TE, Harvey RG, Penning TM (1988) Oxidation of the trans-3,4-dihydrodiol metabolites of the potent carcinogen 7,12-dimethylbenz(a)anthracene and other benz(a)anthracene derivatives by 3 alpha-hydroxysteroid-dihydrodiol dehydrogenase: effects of methyl substitution on velocity and stereochemical course of trans-dihydrodiol oxidation. Cancer Res 48:1227–1232

    PubMed  CAS  Google Scholar 

  28. Smithgall TE, Harvey RG, Penning TM (1988) Spectroscopic identification of ortho-quinones as the products of polycyclic aromatic trans-dihydrodiol oxidation catalyzed by dihydrodiol dehydrogenase. A potential route of proximate carcinogen metabolism. J Biol Chem 263:1814–1820

    PubMed  CAS  Google Scholar 

  29. Sodhi A, Gupta P (1986) Increased release of hydrogen peroxide (H2O2) and superoxide anion (O2 -) by murine macrophages in vitro after cis-platin treatment. Int J Immunopharmacol 8:709–714

    Article  PubMed  CAS  Google Scholar 

  30. Spitz DR, Phillips JW, Adams DT, Sherman CM, Deen DF, Li GC (1993) Cellular resistance to oxidative stress is accompanied by resistance to cisplatin: the significance of increased catalase activity and total glutathione in hydrogen peroxide-resistant fibroblasts. J Cell Physiol 156:72–79

    Article  PubMed  CAS  Google Scholar 

  31. Sung YJ, Cheng CL, Chen CS, Huang HB, Huang FL, Wu PC, Shiao MS, Tsay HJ (2003) Distinct mechanisms account for beta-amyloid toxicity in PC12 and differentiated PC12 neuronal cells. J Biomed Sci 10:379–388

    PubMed  CAS  Google Scholar 

  32. Timmer-Bosscha H, Mulder NH, de Vries EGE (1992) Modulation of cis-diamminedichloroplatinum(II) resistance: a review. Br J Cancer 66:227–238

    PubMed  CAS  Google Scholar 

  33. Zvereva E, Serebrov V, Glupov V, Dubovskiy I (2003) Activity and heavy metal resistance of non-specific esterases in leaf beetle Chrysomela lapponica from polluted and unpolluted habitats. Comp Biochem Physiol C Toxicol Pharmacol 135:383–391

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Henry Simpkins.

Additional information

This research was supported by NIH Grant CA98804 to H.S.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, J., Adikari, M., Pallai, R. et al. Dihydrodiol dehydrogenases regulate the generation of reactive oxygen species and the development of cisplatin resistance in human ovarian carcinoma cells. Cancer Chemother Pharmacol 61, 979–987 (2008). https://doi.org/10.1007/s00280-007-0554-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00280-007-0554-0

Keywords

Navigation